Richard Smalling photo

Richard W. Smalling

James D. Woods Distinguished Chair in Cardiovascular Medicine, and Director of Interventional Cardiovascular Medicine, Division of Cardiology 
McGovern Medical School at UTHealth and Memorial Hermann Heart and Vascular Institute

B.S. ASE 1970, The University of Texas at Austin
M.S. ME 1972, The University of Texas at Austin
Medicine 1975, McGovern Medical School at UTHealth
Ph.D. 1977, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences

Dr. Smalling is a native Texan who received his B.S. in Aerospace Engineering and M.S.M.E. in Bio-Medical Engineering from UT Austin, and PhD from what is now The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences.  He is an AOA graduate of McGovern Medical School at UTHealth and did his residency training and cardiology fellowship at the University of California-San Diego. Board certified in internal medicine, cardiovascular medicine, and interventional cardiology, he is Past President of the American Heart Association, Texas Affiliate, and Past President of the Medical Staff of Memorial Hermann-Texas Medical Center where he was also named a Distinguished Physician.  He has been honored as a Distinguished Alumnus of both McGovern Medical School (1991) and the Cockrell College of Engineering at the University Texas at Austin (1997).

Named an America’s Top Doctor for the past fifteen years, Dr. Smalling received the Distinguished Service Award from the American Heart Association Texas Affiliate in 1990.  He is on the editorial boards of Catheterization and Cardiovascular Interventions, The Journal of Interventional Cardiology, and Journal of the American College of Cardiology- Interventions and is a past associate editor for Circulation. In 2016, he was named a Master in the Society of Catheterization and Cardiovascular Interventions. In addition, he holds six patents and Co-founded Windmill Cardiovascular Systems, to produce a new implantable left ventricular assist device.  He and his team has developed the first valveless, pulsatile flow LVAD that pumps in synchrony with the cardiac cycle and automatically changes its pumping function to optimize cardiac function.  

Dr. Smalling specializes in the treatment of valvular heart disease and adult congenital heart disease percutaneously.  His research interests include development of 3-D, fluoroscopically guided structural heart interventions and reduction of reperfusion injury by mechanical LV unloading and endothelin inhibition. Clinically, his team is actively pursuing the role of very early treatment of patients with acute myocardial infarction and evaluating new percutaneous methodologies for treating valvular heart disease.

Dr. Smalling is the author of over 250 peer-reviewed articles, 25 book chapters, 2 books, and more than 15 web-based CME articles.  He and his wife Sharon have 3 children, Geoffrey, Elizabeth and Stephanie and 2 grandchildren.  They enjoy cooking, cycling, skiing and traveling together.